Herbs producer expands in US

Dorot, an Israeli producer of packaged garlic and herbs said Sunday it has expanded its overseas business activities by opening a new subsidiary in the US, which will import and market Dorot products there.

By YONI TEITZ
July 9, 2007 08:13

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Dorot, an Israeli producer of packaged garlic and herbs said Sunday it has expanded its overseas business activities by opening a new subsidiary in the US, which will import and market Dorot products there. Dorot products are currently sold at 1,500 retail and wholesale locations throughout the US. In addition to the US, Dorot exports its products to Canada, the UK, Spain, Germany, Sweden, Denmark, Finland and Iceland. Dorot's flagship products are individual frozen trays of garlic and other herbs.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS